AIとがん研究 ── 腎臓がん ── 2026-11-16
腎臓がん 1 本。筆頭: CT-based AI risk support for cystic renal masses: multicenter validation, reader study, and a randomized implementation study.
腎臓がんの治療・治験とAI
- CT-based AI risk support for cystic renal masses: multicenter validation, reader study, and a randomized implementation study.抄録(全訳)掲載誌の IF 相当:15.2(OpenAlex の直近 2 年の平均被引用数・2026-11-13 時点の値、2026-11-15 に取得。正式な IF(Clarivate)ではない)書誌:Chen C, Kang Q, Yang Y, Li X, Li N, Zhang Q, et al. CT-based AI risk support for cystic renal masses: multicenter validation, reader study, and a randomized implementation study. EClinicalMedicine. 2026 Nov;101:104279. doi:10.1016/j.eclinm.2026.104279. PMID: 43022301.確認の範囲:抄録のみ確認